The upregulation of enzymes such as LPCAT1 has been reported in human colorectal adenocarcinoma [52] and metastatic prostate cancer [53], suggesting the involvement of the LPC metabolism in cancer progression. The gene discussed is LPCAT1; the disease is metastatic prostate carcinoma.